New report published by Global Info Research which offers insights on the global Prostate Cancer Diagnostics market.
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Click to view the full report TOC, figure and tables:
Global Prostate Cancer Diagnostics Market: Forecast by Type / Application / Region
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
Market Segment by Manufacturers covers: Genomic Health, Abbott, OPKO, Siemens Healthcare, DiaSorin, BioMeriux, Roche, MDx Health, Beckman Coulter, Myriad Genetics, Ambry Genetics.
Market Segment by Types covers: Tumor Biomarker Tests , Imaging, Biopsy, Other.
Market Segment by Applications can be divided into: < 55, 55-75, > 75.
In the last several years, global market of Prostate Cancer Diagnostics developed rapidly, with an average growth rate of 5.25%. In 2017, global revenue of Prostate Cancer Diagnostics is 10.01 billion USD.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.
Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.
North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.
Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States Prostate Cancer Diagnostics Market 2018 Forecast to 2023
Europe Prostate Cancer Diagnostics Market 2018 Forecast to 2023
North America Prostate Cancer Diagnostics Market 2018 Forecast to 2023
Asia-Pacific Prostate Cancer Diagnostics Market 2018 Forecast to 2023
China Prostate Cancer Diagnostics Market 2018 Forecast to 2023
EMEA Prostate Cancer Diagnostics Market 2018 Forecast to 2023
Global Prostate Cancer Diagnostics Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong